Literature DB >> 9055003

Breast lymphoma--a pathologic study of 14 cases.

P H Tan1, I T Sng.   

Abstract

Fourteen cases of malignant non-Hodgkin's lymphoma of the breast were diagnosed at the Department of Pathology, Singapore General Hospital, since 1988. All were females with an age range of 30 to 69 years. Twelve cases were B cell and 2 were T cell in immunophenotype. Of the B cell lymphomas, one was subtyped as follicular, 8 diffuse large cell (IWF) or centroblastic (Kiel) and 3 immunoblastic lymphomas. Both T cell tumours were Ki-1 positive, large cell anaplastic lymphomas. Malignant lymphoma was not clinically suspected in any patient at presentation. Histologically, 3 cases were initially diagnosed as carcinomas, one on a trucut biopsy, another during frozen section evaluation and the third was a breast excision specimen. The pathological characteristics and potential histologic problems are detailed. The rarity of the disease, lack of uniform classification and variable treatment modalities make prognostic predictions of breast lymphoma difficult.

Entities:  

Mesh:

Year:  1996        PMID: 9055003

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer--a case report.

Authors:  Florian Rudolf Fritzsche; Stefan Pahl; Iver Petersen; Mick Burkhardt; Anja Dankof; Manfred Dietel; Glen Kristiansen
Journal:  Virchows Arch       Date:  2006-09-16       Impact factor: 4.064

2.  Primary breast lymphoma.

Authors:  Pooja Voria; Peter R Eby; Kimberly Allison
Journal:  Radiol Case Rep       Date:  2015-11-06

3.  Primary breast lymphoma: a pooled analysis of prognostic factors and survival in 93 cases.

Authors:  Mu-Tai Liu; Chang-Yao Hsieh; Ai-Yih Wang; Chu-Ping Pi; Tung-Hao Chang; Chia-Chun Huang; Chao-Yuan Huang
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.